key: cord-1013630-zq64ta46
authors: Patankar, Jay Vasant; Chiriac, Mircea; Lehmann, Malte; Kühl, Anja A.; Atreya, Raja; Becker, Christoph
title: The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn’s disease and regulated by microbial and inflammatory signaling
date: 2020-10-17
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.10.021
sha: 8c8432ea44e42efea903a015d53f9824692253de
doc_id: 1013630
cord_uid: zq64ta46

nan

scholarship from The Polish Ministry of Science and Higher Education Mobility Plus 5 (#1658/MOB/V/2017/0).

The disease now known as COVID-19 (Corona Virus Disease 2019) is caused by a novel betacoronavirus denoted SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2) and was initially reported in December 2019 as pneumonia of unknown cause [1] [2] [3] [4] . Recently, it was described that in humans co-expression of Angiotensin-Converting Enzyme 2 (ACE2) and the transmembrane protease serine 2 (TMPRSS2) promotes the entry of SARS-CoV-2 into host cells 5 .

Recent reports suggest that between 6% and 48% of COVID-19 cases experience digestive symptoms with or without diarrhea as their main complaint at presentation or upon hospitalization 6 . These patients may have worse clinical outcomes than those with respiratory symptoms alone 6 Little is known about the regulation of ACE2 and TMPRSS2 in the gut during inflammation.

Previous studies were inconclusive on the levels of ACE2 in IBD 8 . Here, we present collective results on the regulation of intestinal ACE2 and TMPRSS2 in human and experimental models of intestinal inflammation and present data on the putative signaling mechanisms that control their expression via cytokines and pattern recognition receptors in the gut epithelium.

A total of 129 IBD patients were analyzed across all experiments. The ethics committee of the University Hospital of Erlangen and Charité -University Hospital Berlin, approved experiments involving human material.

C57/Bl6 and Rag2-/-mice were purchased from Charles River Laboratories.

Please refer to the supplemental information for details on mouse strains, materials, and methods.

J o u r n a l P r e -p r o o f Results Interestingly, ACE2, but not TMPRSS2 expression was substantially lower in inflamed ilea (score 3) of Crohn's disease (CD) patients than uninflamed controls (score 0), and correlated negatively with the expression of an established inflammation marker, S100A8 (Fig.1A) .

Contrary to CD, and consistent with previously published datasets, the expression level of ACE2 and TMPRSS2 remained unchanged in the inflamed colon of ulcerative colitis (UC) patients ( Fig.S1A-B) . Quantitative immunohistochemical analysis revealed a reduction in ACE2, but not TMPRSS2 protein in the inflamed ilea of CD patients, but not in the colon of UC patients ( Fig.1B-C, Fig.S1C ). These data show that transcript and protein levels of ACE2 are reduced in inflamed CD ileum. To systematically investigate how inflammation alters ACE2 and TMPRSS2 expression, we performed RNA-sequencing from control and inflamed tissues from multiple well-established mouse models. In all models tested, the expression of Interferon (IFN) responses are induced during viral infections and in IBD. In our experiment comparing transcriptome-wide responses to IFNs from wild-type, Stat1 -/-, and Stat2 -/organoids, we observed strong repression of Ace2 in response to IFN-β and -λ and of Tmprss2 to IFN-γ (Fig.1G) . Interestingly, such suppression was absent in organoids from Stat1 -/mice (Fig. 1G) . However, the IFN-mediated Ace2 downregulation was still apparent in Stat2 -/organoids (Fig.1G) . Thus, IFN-mediated Ace2 repression in IEC requires STAT1, but not STAT2. Furthermore, expression of intestinal Ace2 was repressed in mice overexpressing IFN-λ (Fig.1H ). Type-2 immune responses are predominant in UC.

Stimulation of intestinal organoids with the IL-13, a key UC type-2 cytokine showed a significant upregulation of Ace2 but not Tmprss2 transcripts (Fig.1I ). Of note, such upregulation was absent in organoids from mice lacking Stat6 (Fig.1I ). Collectively, these data indicate that IEC Ace2 is regulated reciprocally by IL-13:STAT6 versus IFN:STAT1 signaling.

Immense person-to-person variation is reported for COVID-19, and the composition of gut microbiota, among other factors, could account for this. Interestingly, germ-free (GF) mice showed a 2-fold increase in the expression of intestinal Ace2 versus specific-pathogen-free (SPF) mice (Fig. 1J) , which was similar to the analysis of two previous datasets comparing antibiotic-treated and GF mice versus controls (Fig. 1K, Fig.S2A ). Challenging wild-type mice J o u r n a l P r e -p r o o f with LPS, a TLR4 agonist, or poly(I:C), a TLR3 agonist revealed a strong downregulation of intestinal Ace2, but not Tmprss2 (Fig.1L, Fig.S2B ). Analysis of a previous dataset of GF mice monoassociated with Citrobacter rodentium also showed similar results (Fig.S2C ). Taken together, our data provide strong evidence that microbial signaling via TLRs regulates intestinal Ace2.

The spread of COVID-19 to countries with high incidence rates of IBD and recent studies showing SARS-CoV-2's ability to infect gastrointestinal cells have raised concerns on the severity of COVID-19 in IBD patients. A crucial yet poorly known aspect is the understanding of how the SARS-CoV-2 receptors are regulated on IEC. In this regard, we first found that CD differed from UC in which the expression of ACE2 was repressed in inflamed CD, but not UC tissues. Interestingly, Ace2 was repressed in murine colitis models where Type-1 cytokines predominate, whereas UC involves a Type-2-like immune response. Our study showed that IEC Ace2 is regulated differentially based on the predominant cytokine response and stage of inflammation highlighting the need for further investigation.

Interestingly we found that Ace2, but not of Tmprss2 mRNA expression correlated with the presence of gut microbiota with a strong negative correlation in various mouse models and publicly available datasets. Whether such regulation of ACE2, via commensal flora, also occurs in human IEC is still to be determined. It is tempting to speculate that the composition of commensal microbiota is linked to the individual differences in COVID-19 susceptibility.

Our findings suggest that treatment with antibiotics could influence the expression levels of mucosal ACE2 and alter the susceptibility of IEC to be infected by the SARS-CoV-2. Overall, our study uncovers novel regulatory effectors of IEC ACE2 that impact its expression in IBD.

Our data indicate that the large surface area of the gut may act as an amplifier of SARS-CoV-2. 

The induction of various experimental colitis was performed as previously described 2 . For chronic colitis, mice were challenged with 3 cycles of 1.5% dextran sulfate sodium (DSS) in drinking water interleaved by 2 cycles of normal drinking water. Oxazolone colitis was induced by initially pre-sensitizing the mice by the application of 3% oxazolone solution in an acetone-olive oil delivery solution onto shaved skin. On day 8 post-sensitization, mice were anesthetized and a rectal cannula was instilled to deliver 100µl of the 3% oxazolone solution as enema. T-cell transfer colitis was initiated in mice as described previously 3 . In short, recipient Rag2 -/mice were injected intraperitoneal with isolated and purified T-cells and the course of disease was followed by assessing disease scores for general appearance, body weight, rectal bleeding and stool consistency. Hs_HPRT(F-cctggcgtcgtgattagtgat; R-agacgttcagtcctgtccataa )

Cryosections were thawed, fixed in 4% PFA, washed, blocked and incubated with anti-TMPRSS2 (abcam, ab92323, 1:100) overnight. Sections were washed and primary antibodies were detected using secondary antibodies and nuclei were counter stained with Hoechst (Thermo Fsicher Scientific GmbH, Erlangen, Germany). Paraformaldehyde fixed, paraffin embedded tissue sections were dewaxed and subjected to antigen retrieval using Tris-EDTA. Tissues were washed, blocked and incubated overnight with anti-ACE2 (Abcam, ab15348, 1:100) followed by washes and detection using labelled secondary antibodies and nuclear counter staining with Hoechst. Images were acquired using the Leica TCS SP5 confocal microscope using appropriate settings. For double staining, paraffin sections were dewaxed and subjected to heat-induced retrieval prior to incubation with primary antibody directed against ACE2 (Abcam, clone EPR4435(2), 1:4000) followed by incubation with peroxidase-labelled secondary antibody employing the EnVision+ System-HRP Labelled Polymer (Agilent). For detection, OPAL670 (Akoya Biosciences) was used. Proteins and enzymes were inactivated (antibody stripping) and sections were incubated with the second primary antibody directed against TMPRSS2 (Abcam clone EPR3861, 1:50,000) followed by incubation with peroxidase-labelled secondary antibody employing the EnVision+ System-HRP Labelled Polymer (Agilent). For detection, OPAL520 (Akoya Biosciences) was used.

Nuclei were stained using 4′,6-diamidine-2′-phenylindole dihydrochloride (DAPI; Sigma) and sections were coverslipped using Fluoromount G (Southern Biotech). Pictures were acquired J o u r n a l P r e -p r o o f by the Zeiss AxioImager Z1 microscope (Carl Zeiss MicroImaging). For analysis, five pictures at 400X magnification of each section were taken in black and white and subjected to grayscale analysis employing ImageJ (version 1.8.0_112). For the immunohistochemical detection of ACE2, a heat-induced antigen retrieval at pH 6 was performed. The sections were incubated with primary antibody against ACE2 (Abcam, clone EPR4435(2), 1:1,000) for 30 minutes at room temperature. The primary antibodies were detected using and detected using the EnVision+ System-HRP Labelled Polymer and 3,3'-Diaminobenzidine (DAB, Agilent) was used as chromogen. Sections were counterstained with hematoxylin (Merck Millipore, GmbH, Darmstadt, Germany) and slides were coverslipped with glycerol-gelatine (Merck, GmbH, Darmstadt, Germany).

For analyzing the gene expression correlations, we used the Gene Expression Omnibus (GEO) through which the following publicly available datasets were obtained GSE16879 4 , with featurecounts, v1.6.4. Analyses were performed using the freely available tools STAR, version 2.7.0d, to map against indexed genomes; and deseq2 version 1.24.0 R package to perform the differential expression analysis.

Analysis of grouped data was performed using two-parameter analyses of variance followed by Dunnett's post hoc-test. Multi-column comparisons were performed using one-way analysis of variance Dunnett's post hoc-test. Comparisons between data sets were performed using Student's t-test. All calculations were performed in GraphPad Prism 

The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

A Novel Coronavirus from Patients with Pneumonia in China

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

SARS-CoV-2 productively infects human gut enterocytes

Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

Chemically induced mouse models of acute and chronic intestinal inflammation

NLRP6 Deficiency in CD4 T Cells Decreases T Cell Survival Associated with Increased Cell Death

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment

Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer

A single-cell survey of the small intestinal epithelium

Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice

Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells

Acknowledgements: This work received funding from the DFG projects SFB1181 (C05), TRR241 (A02, A03, B01, C02, C04 and INF), KFO257 and individual grant BE3686/2. The project was further supported by the Interdisciplinary Center for Clinical Research (IZKF: J68, A76). Y.Y was supported by the China Scholarship Council and MZ was supported by a

Author names in bold designate shared co-first authorship J o u r n a l P r e -p r o o f